Rapid Onset Gender Dysphoria

The American Psychological Association and 61 other health care providers’ organizations signed a letter in 2021 denouncing the validity of rapid-onset gender dysphoria (ROGD) as a clinical diagnosis. And a steadily growing body of scientific evidence demonstrates that it does not reflect transgender adolescents’ experiences and that “social contagion” is not causing more young people to seek gender-affirming care. Still, the concept continues to be used to justify anti-trans legislation across the U.S.

“To even say it’s a hypothesis at this point, based on the paucity of research on this, I think is a real stretch,” says Eli Coleman, former president of the World Professional Association for Transgender Health. Coleman helped create the organization’s most recent standards of care for trans people, which endorse and explain the evidence for forms of gender-affirming care.